Life Sciences Update
The Impact of the EU Pharma Package on market access, IP, promotion, market exclusivity and investments
We are pleased to announce our next Life Sciences Update event at Gorrissen Federspiel on 5 November 2026, from 9.00 – 13.00 (CET).
This edition will focus on the impact of the EU Pharma Package on market access, IP, promotion, market exclusivity and investments.
While the programme is still being finalised, we can already share that it will explore the strategic, legal, commercial and financial considerations shaping the industry as it adapts to the new legal and commercial framework established by the upcoming EU Pharma Package.
Through expert presentations and discussions, participants will gain insights into:
- Adapting or rethinking promotional activities
- Maret access stragtegy impacts
- Navigatibng modulated incentives for market exclusivity and IP
- Understanding the investor’s outlook on the life sciences industry
The event features speakers from leading life sciences companies and organisations, including AstraZeneca, Boehringer Ingelheim, LIF and Copenhagen Economics.
Subsequently, a light lunch will be served, providing an opportunity for networking.
Program
We are currently finalizing the agenda and will share more information here soon.
Time and venue
Date: Thursday, 5 November 2026
Time: 9.00 – 13.00 (CET) with breakfast and registration from 8.30 (CET)
Venue: Gorrissen Federspiel, Axel Towers, Axeltorv 2, 1609 Copenhagen V
Registration
Participation in the event is free of charge. Please register below.